The one thing that everyone must take notice of is the fact that we are asking for HIGHER royalties. How can this be a bad thing? It only emphasizes the fact that RECAF is ready and it works. The only hold up is clinical trials and if we have to do this with Inverness you will pay us us for not living up to your end of the contract.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.